Company Filing History:
1 out of 167 
1 out of 189 Years Active: 2020
Title: The Innovative Mind of Duncan Robert R Hiscock
Introduction
Duncan Robert R Hiscock, based in Amersham, GB, is a notable inventor with a keen focus on advancements in medical imaging techniques. His innovative contributions are particularly significant in the realm of oncology, where his work aids in the monitoring and diagnosis of tumors and cancers.
Latest Patents
Hiscock holds a patent for his invention related to HER2 polypeptides that are useful for imaging and monitoring tumors and cancers. The patent details a method utilizing an isolated polypeptide conjugated with a radionuclide. This isolated polypeptide is specifically designed to bind to HER2 or its variants, providing a means to monitor the response to HSP90 inhibition. The application outlines the use of a polypeptide conjugated with 18F as an imaging agent, providing critical insight into the effectiveness of cancer therapies.
Career Highlights
Throughout his career, Duncan has been associated with prominent companies that emphasize innovation in healthcare. Notably, he has worked for Imperial Innovations Limited and GE Healthcare Limited, contributing to their research and developmental efforts in medical technologies.
Collaborations
His work has included collaborations with esteemed professionals in the field, including Eric Ofori Aboagye and Peter Brian Iveson. Together, they have worked towards enhancing the capabilities of medical imaging and cancer treatment methodologies, showcasing the importance of teamwork in scientific advancements.
Conclusion
Duncan Robert R Hiscock stands out as a pioneering inventor in the field of medical imaging. His patent for HER2 polypeptides represents a significant step forward in cancer monitoring and treatment. With his extensive experience and collaborative efforts, Hiscock continues to make impactful contributions that advance health technology and improve patient outcomes.